Table 3.
Antihypertensive Medication Summary by Drug Class
| Percent of Patients | ||||
|---|---|---|---|---|
| Baseline | End-of-study | |||
| Control (n=78) |
Intervention (n=101) |
Control (n=68) |
Intervention (n=92) |
|
| Medication Class | ||||
| Diuretics | 42.3% | 48.5% | 58.8% | 87.0% a |
| Beta-adrenergic Blockers | 38.5% | 36.6% | 45.6% | 39.1% |
| ACE Inhibitor | 30.8% | 41.6% | 39.7% | 64.1% b |
| Angiotensin Receptor Blockers | 16.7% | 9.9% | 19.1% | 13.0% |
| Calcium Channel Blockers | 15.4% | 17.8% | 29.4% | 33.7% |
| Alpha-adrenergic Blockers | 2.6% | 1.0% | 1.5% | 2.2% |
| Central Alpha-adrenergic Blockers | 0 | 1.0% | 0 | 1.1% |
| Vasodilators | 1.3% | 0 | 2.9% | 1.1% |
| Aldosterone Blockers | 0 | 0 | 0 | 4.4% |
a
p<0.0001
b
p=0.0022, Pearson chi-square tests (all compared to control group). Unless otherwise indicated, groups were not significantly different.